跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,229 条关于
“Biohaven Ltd”
全部
9,229
临床试验
1,691
药物
1,499
机构
4,088
资讯
1,951
去年
Biohaven's Pipeline Advances Drive Optimistic Outlook for 2025
去年
Biohaven Announces Topline Results of Troriluzole Trial in Spinocerebellar Ataxia
去年
Biohaven Announces Third Quarter 2024 Financial Results and Business Developments
去年
Biohaven Withdraws EU Application for Spinocerebellar Ataxia Drug Dazluma
8个月前
Biohaven's Major Depressive Disorder Drug Fails Phase 2 Trial Primary Endpoint
去年
Biohaven Secures $600 Million Non-Dilutive Funding from Oberland Capital for Rare Disease Drug Development
去年
Biohaven Launches Phase 2 Trial of TRPM3 Antagonist BHV-2100 for Acute Migraine Treatment
2个月前
Biohaven Reshapes Scientific Leadership: Pirman Promoted to Head of Discovery, Car Transitions to Chief Innovation Officer
去年
Biohaven's BHV-1400 Demonstrates Rapid Reduction of Gd-IgA1 in Phase 1 Trial for IgA Nephropathy
8个月前
Biohaven's BHV-7000 Fails to Meet Primary Endpoint in Phase 2 Major Depression Trial
第 1 页,共 196 页
上一页
下一页